The length of hospital stays and death among patients with chronic obstructive pulmonary disease are tied to various ...

The first oral pill for obstructive sleep apnea (OSA) could be around the corner after pharmaceutical company Apnimed Inc.

In today’s Health Alert, obstructive sleep apnea may soon be treated with a simple, once-a-day pill. This first-in-class oral ...

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with OSA.

First French President Emmanuel Macron announced that France would recognize the state of Palestine ahead of the General ...

Four WVU Medicine hospitals have been named by U.S. News & World Report to its 2025-2026 Best Hospitals as High Performing ...

Analysts are estimating that Inspire Medical Systems will report an earnings per share (EPS) of $0.21. Anticipation surrounds ...

Four WVU Medicine hospitals have been named by U.S. News & World Report to its 2025-2026 Best Hospitals as high-performing hospitals for 19 procedures and conditions. This is the highest distinction a ...

Franklin Templeton’s ClearBridge International Value Fund beat its benchmark in Q2 2025. See how smart stock picks and global ...

The data highlight the scope of the troubling relationship being seen even in regions with relatively low levels of pollution ...

Legacy Dental is excited to announce a significant enhancement to its services: the introduction of customized oral ...

Topline results from a second phase 3 trial of AD109-an investigational oral therapy combining aroxybutynin and ...